Some studies have suggested that IL-1β, TNF-α, IL-2, IFN-γ, and IL-6 were markedly upregulated in critical patients after infection with SARS-CoV-2 and thus can be used as biomarkers to determine the severity of disease in patients (27, 31). The gene discussed is TNF; the disease is infection.